Search

everythinglearnresearchcommunity

for

Search:↓

Steroidogenesis inhibitors change but don't stop androgen production in prostate cancer.

3-tetrazolo steroidal analogs can strongly inhibit the enzyme linked to hair loss.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

New compounds show promise as nonsteroidal treatments for hair loss.

New chemical compounds were made that effectively block an enzyme linked to prostate growth.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

Finasteride reduces melanin production in skin cells.

Antiandrogen therapy helps treat genetic hair loss.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Hair loss treatment using stem cells from baby teeth was effective for 75% of men tested, with mild side effects. A scoring system may predict how well this treatment works.

Lack or blocking of SRD5a, a key component in hormone creation, can lead to conditions like pseudohermaphrodism and affect hair growth, bone mass, muscle strength, and reproductive health. More research is needed on its regulation from fertilization to adulthood.

A new compound may effectively inhibit the enzyme linked to BPH and hair loss.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Some newly made compounds can block an enzyme linked to hair loss and prostate growth, with one in particular being very selective.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Anti-androgen drugs can treat conditions like prostate cancer and male pattern baldness by blocking effects of testosterone and DHT.

Inhibitors of the enzyme 5 alpha-reductase could potentially treat disorders like prostate cancer and baldness.

Aromatase inhibitors cause male pattern hair loss in women.

New treatments for enlarged prostate are being developed, some of which may be more effective than current medications.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Dihydrotestosterone (DHT) increases oil production in skin cells by activating mTOR, and mTOR inhibitors can reduce this effect.

Muscles can make their own androgens, which may help muscle growth.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Clascoterone may be an effective topical treatment for hair loss.

Hair loss can be managed with treatments like minoxidil, finasteride, and others, but there are still gaps in effectiveness and off-label usage is increasing.

Suppressing certain hormones might help prevent prostate cancer.

Post-Finasteride Syndrome causes lasting sexual, mood, and metabolic issues, needing personalized treatment and better informed consent.

Isotretinoin and tazarotene help treat acne, while minoxidil and finasteride promote hair growth.

Levamisole and finasteride can reduce DHT production, potentially preventing phenytoin-induced gum overgrowth.

Blocking DHT production more strongly may help control advanced prostate cancer and improve quality of life.